Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
Main Author: | Christian J Wiedermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2016-01-01
|
Series: | Chinese Medical Journal |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=1;spage=116;epage=117;aulast=Wiedermann |
Similar Items
-
Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression
by: Peng-Lin Ma, et al.
Published: (2015-01-01) -
Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
by: Chung-Sik Oh, et al.
Published: (2012-04-01) -
Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
by: Ornella Piazza, et al.
Published: (2010-09-01) -
Effects of hydroxyethyl starch 130/0.4 on the kidney tissue of rats with ureteral obstruction
by: Güneş I, et al.
Published: (2018-09-01) -
In-vitro-Effekt von Hydroxyethylstärke 130/0,42 auf die canine Thrombozytenfunktion
by: Claßen, Janine
Published: (2013)